Metoclopramide Injection, Solution
Product Images NDC 51662-1367

13 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Metoclopramide (NDC 51662-1367). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Boxed Warning (Boxed Warning)

Boxed Warning (Boxed Warning)
A drug warning text panel titled 'WARNING: TARDIVE DYSKINESIA' describing the risk of tardive dyskinesia with metoclopramide treatment. It advises discontinuing therapy if symptoms develop and notes no known treatment for the disorder, with symptoms sometimes improving after stopping metoclopramide. It warns against use longer than 12 weeks except in rare cases where benefits outweigh risks.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of metoclopramide, the active ingredient in the injection solution. The diagram shows the molecular components including chlorine, amino, methoxy groups, and the diethylamino side chain with hydrochloride and water molecules.*
FDA Label Image

Clinical Pharma 1 (Clinical Pharma 1)

Clinical Pharma 1 (Clinical Pharma 1)
A data table presenting pharmacokinetic parameters including volume of distribution (~3.5 L/kg), plasma protein binding (~30%), half-life (t ½) of 5 to 6 hours, and oral bioavailability (80% ± 15.5%). The table contains two columns labeled 'Parameter' and 'Value' with alternating row colors for readability.*
FDA Label Image

Clinical Pharma 2 (Clinical Pharma 2)

Clinical Pharma 2 (Clinical Pharma 2)
A table presenting pharmacokinetic parameters of Metoclopramide for two different dosing regimens. It includes columns for dose and route, half-life (t1/2), clearance (Cl), volume of distribution (Vd), and maximum concentration (Cmax) with numerical values for each parameter under two reference conditions.*
FDA Label Image

How Supplied 1 (How Supplied 1)

How Supplied 1 (How Supplied 1)
An instructional diagram of a syringe showing components labeled with usage instructions: the 'Syringe Tip Cap' to be removed, the 'Plastic Wrap' and 'External Collar' which should not be removed. The diagram likely relates to the preparation or administration of an injection.*
FDA Label Image

How Supplied 2 (How Supplied 2)

How Supplied 2 (How Supplied 2)
A black-and-white line drawing showing two hands holding a syringe. One hand grips the barrel of the syringe while the other hand holds the plunger rod, illustrating the preparation or administration technique for an injection.*
FDA Label Image

How Supplied 3 (How Supplied 3)

How Supplied 3 (How Supplied 3)
An instructional illustration showing two hands holding a syringe, with an arrow indicating a twisting motion. The image likely demonstrates how to attach or prepare the syringe for injection.*
FDA Label Image

Logo (Logo How Supplied)

FDA Label Image

Logo (Logo Medication Guide)

FDA Label Image

Syringe Label 2 (Syringe Label 2)

Syringe Label 2 (Syringe Label 2)
Label for Metoclopramide injection, USP, 10 mg/2 mL (5 mg/mL) single-use solution intended for IV or IM administration. The label includes a volume scale from 0.5 to 2 mL, a barcode, and the manufacturer name Fresenius Kabi. The product is prescription-only.*
FDA Label Image

Syringe Label 1 (Syringe Label 1)

Syringe Label 1 (Syringe Label 1)
Label for Metoclopramide Injection, USP 10 mg/2 mL (5 mg/mL) in a 2 mL prefilled single-use syringe. Intended for intravenous or intramuscular use, prescription only. Includes storage instructions, usage directions, and barcodes. Labeler is HF Acquisition Co LLC, DBA HealthFirst.*
FDA Label Image

Serialized Labeling (Serialized Syringe Labeling Blister Pack)

Serialized Labeling (Serialized Syringe Labeling Blister Pack)
A vial label for Metoclopramide injection USP, 10 mg/2 mL (5 mg/mL) solution for intramuscular and intravenous use. The label includes FDA barcodes, storage instructions to keep at 20 to 25°C, a note about discarding unused portions, and is distributed by HF Acquisition Co LLC, Mukilteo, WA 98275. The label features the NDC 76045-101-20 and emphasizes single use only for IV or IM administration.*
FDA Label Image

Syringe In Blister Pack (BACK)

Syringe In Blister Pack (BACK)
METOCLOPRAMIDE 10 mg/2 mL injection solution in a prefilled syringe, labeled for prescription use (Rx only). The syringe is sealed in a clear plastic blister pack and displays dosage and barcode information. The product is intended for intramuscular or intravenous administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.